The page is the record's research on the issuer — no analyst, no rating, no view.

Bright Minds Biosciences Inc. (DRUG) — research page

CA · ca-cm-kg/CSE/DRUG · as of 2026-11-06

Identity and listing

The issuer is Bright Minds Biosciences Inc., listed on the CSE under the ticker DRUG. The ISIN and LEI are not on the record, as no ISIN was found on issuer pages. The security type is Corporate, the sector is Life Sciences, and the segment and jurisdiction are not on the record. The listing status is listed, not halted.

fieldvaluesource · read date
nameBright Minds Biosciences Inc.source · 2026-11-06
exchangeCSEsource · 2026-11-06
tickerDRUGsource · 2026-11-06
ISINnot on the record
LEInot on the record
security typeCorporatesource · 2026-11-06
segmentnot on the record
sectorLife Sciencessource · 2026-11-06
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 17 filings in the twelve months to 2026-11-06, all of them newswire releases, across 13 filing days. The median gap between filing days is 9.5 days. The latest filing is a newswire release dated 2026-11-04, 2 days before the record date. The CSE peer median gap is 19.5 days, and the Life Sciences sector peer median gap is 17.5 days. The CSE peer median filings count is 6.0 and the sector peer median is 7.0. The CSE peer median latency is 17.0 days and the sector peer median latency is 14 days.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer179.52
exchange median: CSE (724 issuers)619.517
sector median: Life Sciences (200 issuers)717.514
datetypecategoryfiling
2026-11-04newswire_releaseBRIGHT MINDS BIOSCIENCES INVESTIGATION: DRUG Securities
2026-11-04newswire_releaseBRIGHT MINDS BIOSCIENCES INVESTIGATION: DRUG ...
2026-11-03newswire_releaseDRUG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Bright Minds Biosciences
2026-11-02newswire_releaseBright Minds Biosciences Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Bright Minds Biosciences (DRUG)
2026-11-02newswire_releaseBright Minds Biosciences Provides Update About Planned

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is DeVisser Gray LLP, and its location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag shows the issuer as listed, not halted.

Orderability

Under paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. Under paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.

client categoryoutcome
Paragraph (o) of the definitionACM-200
Paragraph (q) of the definitionACM-200

rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The field has not been read, so the number of research houses named on the issuer's investor-relations page is not on the record.

Open research

The field has not been read, so the count of openly published research notes is not on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. The live record began on 2026-09-10, and the market's earliest sealed date is not on the record.

Sources

6 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://thecse.com/api/webapi/listed-companies/ (identity.exchange)
10.2
https://mcp.ca-cm-kg.ai/events/CSE/DRUG (the disclosure lines)
10.3
https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
10.4
https://thecse.com/listings/bright-minds-biosciences-inc/ (the auditor)
10.5
https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
10.6
https://mcp.ca-cm-kg.ai/record/CSE/DRUG (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"ticker":"DRUG","exchange":"CSE"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:08044a65bd37ec4a.